Company Filing History:
Years Active: 2012
Title: Stéphane Commo: Innovator in Cosmetic Applications
Introduction
Stéphane Commo is a notable inventor based in Chaville, France. He has made significant contributions to the field of cosmetic and therapeutic applications, particularly in the treatment of premature canities. His innovative work has led to the development of a unique patent that addresses this common issue.
Latest Patents
Stéphane Commo holds a patent titled "Uses of BNIPXL-beta in premature canities." This invention concerns the use of a polypeptide that has at least 90% identity with all or part of BNIPXL-beta for cosmetic or therapeutic applications. The patent outlines methods for treating or preventing premature canities in humans, utilizing a polypeptide comprising at least 30 amino acids. Additionally, it includes the use of a molecule with an RNAi sequence that has at least 90% identity with the cDNA sequence of BNIPXL-beta, comprising at least 18 nucleotides. The invention also details methods for screening molecules that can modulate the expression of the gene coding for BNIPXL-beta, aiming to identify agents for cosmetic or therapeutic purposes in pigmentation.
Career Highlights
Stéphane Commo is associated with L'Oréal, a leading company in the cosmetics industry. His work at L'Oréal has allowed him to focus on innovative solutions that enhance beauty and address specific skin concerns. His dedication to research and development has positioned him as a key player in the field.
Collaborations
Throughout his career, Stéphane has collaborated with notable colleagues, including Bruno Bernard and Olivier De Lacharrière. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the cosmetic industry.
Conclusion
Stéphane Commo's contributions to the field of cosmetic applications, particularly through his patent on BNIPXL-beta, highlight his innovative spirit and commitment to addressing important issues like premature canities. His work continues to influence the cosmetic industry and improve the lives of many individuals.